14.59USD-2.47%Mkt Cap: 792.74M USDP/E: —Last update: 2026-06-01
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treat…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap792.74M USD
Enterprise Value322.58M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-695.98M USD
Revenue/Share—
Last Price14.59 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees76
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.00
PEG—
EV/EBITDA-0.94
EV/Revenue—
P/S—
P/B-3.53
EPS (TTM)-70.40
EPS (Forward)-3.74
52W Range
3.62018% of range65.80
52W High65.80 USD
52W Low3.620 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE423.57%
ROA-149.96%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-142.71M USD
CapEx (TTM)941.00K USD
FCF Margin—
FCF Yield-24.69%
Net Debt-488.59M USD
Net Debt/EBITDA1.43
Balance Sheet
Debt/Equity-0.02
Current Ratio31.15
Quick Ratio30.57
Book Value/Sh-4.2440 USD
Cash/Share9.071 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 19, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)37.88 USD
Target Range18.00 USD – 50.00 USD
# Analysts8
Ownership
Shares Out.54.19M
Float43.71M
Insiders4.29%
Institutions69.39%
Short Interest
Short Ratio4.9d
Short % Float10.14%
Short % Out.8.48%
Shares Short4.60M
Short (prev mo.)4.71M
Technical
SMA 5015.09 (-3.3%)
SMA 20019.84 (-26.5%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)816.56K
Avg Vol (10d)797.20K
Technical Indicators
RSI (14)49.2
MACD-0.0894
MACD Signal-0.0496
MACD Hist.-0.0398
BB Upper17.18 USD
BB Middle15.25 USD
BB Lower13.33 USD
BB Width25.27%
ATR (14)0.9967 USD
Vol Ratio (20d)0.34x